OpenScience.ink

4 weeks ago • Obesity science & practice

Healthcare Professionals’ Views on Injectable GLP-1 Medicines for Treating ObesityAttitudes Toward Injectable GLP-1 Drugs for Obesity Treatment: A Qualitative Interview Study With Healthcare Professionals.

📖 Top 30% JournalArticle

2 weeks ago • SAGE open medical case reports

Open Eustachian Tube Problems After Fast Weight Loss Linked to Semaglutide Use: A Case ReportPatulous Eustachian tube dysfunction following rapid weight loss associated with semaglutide use: A case report.

Case Reports

3 days ago • Rapid communications in mass spectrometry : RCM

Tracking Retatrutide Levels in Human Blood and Urine for Anti-Doping TestsDetection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis.

📖 Top 50% JournalArticle

2 weeks ago • Frontiers in gastroenterology (Lausanne, Switzerland)

Safety, benefits, and anti-inflammatory actions of glucagon-like peptide 1 receptor treatments in inflammatory bowel diseaseGlucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms.

📖 Top 50% JournalArticle

4 weeks ago • Frontiers in urology

Comparing glucagon-like peptide-1 receptor drugs and other diabetes medicines in prostate cancer patients receiving hormone therapyGlucagon-like peptide-1 receptor agonist versus other anti-diabetic agents on patients with prostate cancer undergoing androgen-deprivation therapy.

Article

1 week ago • Journal of International Society of Preventive & Community Dentistry

📖 Top 50% JournalArticle

yesterday • Diabetology & metabolic syndrome

Effects of GLP-1 and GLP-1/GIP receptor drugs before, during, and after pregnancyImpact of GLP-1 and GLP-1/GIP receptor agonists before, during, and after pregnancy: a narrative review.

📖 Top 20% JournalArticle

yesterday • British journal of clinical pharmacology

Using GLP-1 and related drugs to treat heart, liver, and metabolism problems in fatty liver diseaseTargeting the cardiohepatic-metabolic axis: GLP-1-based and incretin multi-agonist therapies in MASH.

📖 Top 20% JournalArticle

yesterday • Therapeutic advances in endocrinology and metabolism

Quality and trustworthiness of health information about GLP-1 diabetes drugs on TikTok and BilibiliAssessing the quality and reliability of health information on GLP-1 receptor agonists on TikTok and Bilibili: a cross-sectional analysis of the public health infodemic.

🎖️ Top 10% JournalArticle

2 days ago • International journal of spine surgery

Do Diabetes Drugs Affect Recovery After Lower Back Fusion Surgery? A Review and AnalysisDo Preoperative Glucagon-Like Peptide-1 Receptor Agonists Influence Lumbar Fusion Outcomes? A Systematic Review and Meta-Analysis.

📖 Top 30% JournalArticle

2 days ago • Heart rhythm

How Two Diabetes Medicines Alone or Together May Affect Atrial Fibrillation Return and Heart Health After Ablation TreatmentThe Effect of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors Alone and in Combination on AF Recurrence and Cardiovascular Outcomes after Catheter Ablation for Atrial Fibrillation.

🥉 Top 5% JournalArticle

2 days ago • Advances in nutrition (Bethesda, Md.)

Epigenetic Memory May Explain Weight Regain After Incretin TreatmentThe Incretin Mirage: Epigenetic Memory as a Potential Driver of Post-Treatment Weight Regain.

🥉 Top 5% JournalArticle

2 days ago • Childhood obesity (Print)

Nutritional Deficiencies, Health Issues, and Diet Support in Children Taking GLP-1 MedicinesNutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists.

📖 Top 30% JournalArticle

3 days ago • Nature metabolism

Combination of cagrilintide and retatrutide improves weight loss and metabolism in obese male ratsCagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male rats.

🥇 Top 1% JournalArticle

3 days ago • Bioorganic chemistry

Deoxycalyxin A lowers blood sugar by activating TGR5 to increase GLP-1 through a specific signaling pathwayDeoxycalyxin A exerts hypoglycemic effects through activating TGR5-induced GLP-1 secretion via TGR5/PKA/MEK/ERK pathway.

📖 Top 30% JournalArticle

3 days ago • JAMA cardiology

Semaglutide’s effectiveness and safety in people with different levels of frailtyEfficacy and Safety of Semaglutide According to Frailty Status: A Post Hoc Analysis of the SELECT Randomized Clinical Trial.

🥇 Top 1% JournalArticle

3 days ago • American journal of respiratory and critical care medicine

GLP-1 receptor drugs and their ability to prevent sleep apnea in people with type 2 diabetesEffectiveness of GLP-1 receptor agonists to prevent obstructive sleep apnea in patients with type 2 diabetes: active comparator, new user cohort study.

🥇 Top 1% JournalArticle

4 days ago • World psychiatry : official journal of the World Psychiatric Association (WPA)

Agreed clinical and research guidelines for using glucagon-like peptide-1 receptor drugs in treating eating disordersConsensus-based clinical and research recommendations for use of glucagon-like peptide-1 receptor agonists in the context of eating disorders: a modified Delphi study.

🏆 Top 0.1% JournalArticle

4 days ago • North American Spine Society journal

Do drugs that activate GLP-1 receptors affect healing after neck bone fusion? A review and combined analysisDo glucagon-like peptide-1 receptor agonists influence cervical fusion outcomes? A systematic review and meta-analysis.

📖 Top 20% JournalArticle

4 days ago • Biological psychiatry global open science

Drugs Targeting GLP-1 and GIP/GLP-1 Receptors for Alcohol Use, Obesity, and Heart-Related Metabolism ProblemsGLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction.

🎖️ Top 10% JournalArticle

4 days ago • Metabolism: clinical and experimental

Avexitide’s effectiveness and safety for low blood sugar after weight-loss and other upper stomach surgeries: a phase 2b studyEfficacy and safety of avexitide for treatment of hypoglycemia following bariatric and other upper gastrointestinal surgeries: a phase 2b study.

🥈 Top 2% JournalArticle

5 days ago • Biomedical journal

Using Incretin-Based Treatments in Patient CareThe Incretin Revolution: Integrating Incretin-Based Therapies into Clinical Care.

📖 Top 20% JournalArticle

5 days ago • The Lancet regional health. Europe

Using incretin-based treatments as part of complete obesity careIntegrating incretin-based therapies into comprehensive obesity care: an EASO position statement.

🥈 Top 2% JournalArticle

5 days ago • The American journal of medicine

Early heart and kidney outcomes after weight-loss surgery with prior use of GLP-1 receptor drugs or TirzepatidePrior GLP-1RA or Tirzepatide Use and Early Cardiorenal Outcomes After Metabolic and Bariatric Surgery.

📖 Top 20% JournalArticle

5 days ago • Obesity pillars

Differences by medical specialty in prescribing weight-loss drugs for obese teens in Saudi ArabiaSpecialty-based variation in glucagon-like Peptide-1 receptor agonist prescribing practices for adolescent obesity in Saudi Arabia.

📖 Top 20% JournalArticle

5 days ago • Obesity pillars

Adjusting weight maintenance after hormone-related weight loss: new strategies beyond just continuing or stopping treatmentAdaptive maintenance after incretin-induced weight loss: Moving beyond the continue-or-stop paradigm.

📖 Top 20% JournalArticle

5 days ago • Clinical oral investigations

How sleep apnea and diabetes drugs affect mouth bacteria and oral healthObstructive sleep apnea, GLP-1 receptor agonist pharmacotherapy, and the oral microbiome: competing biological influences and implications for oral health monitoring.

📖 Top 20% JournalArticle

5 days ago • American journal of physiology. Heart and circulatory physiology

Heart Effects of Long-Term GIPR and GLP-1R Activation in Lean and Obese Mice: Differences by Sex and DoseCardiovascular Effects of Chronic GIPR and GLP-1R Agonism in Lean and Diet-Induced Obese Mice: Sex Differences and Dose-Dependent Remodeling.

🎖️ Top 10% JournalArticle

1 week ago • Antioxidants & redox signaling

SGK2 helps reduce diabetic kidney damage by blocking cell death through NEDD4L-driven ACSL4 breakdownSGK2 Promotes NEDD4L-Mediated ACSL4 Ubiquitination to Inhibit Ferroptosis and Alleviate Diabetic Kidney Disease.

🥉 Top 5% JournalArticle

1 week ago • Dermatology and therapy

Increasing use of GLP-1 and combined GIP/GLP-1 drugs in skin health and treatment, from immune and metabolism effects to patient careThe Expanding Role of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Agonists in Dermatology: From Immunometabolism to Clinical Practice.

🎖️ Top 10% JournalArticle

← prevpage 5 of 14next →

GLP-1 Therapies Research Papers